After half a century of development, robotics technology has proven to be widely used in agriculture, industry, aerospace, military, family, services, and medical fields, providing high economic and social value for human society. Recently, robots have taken another big step in medical applications. Cambridge Medical Robotics (CMR), a UK medical startup, has confirmed that it has received $20.3 million in financing, which will revolutionize the development and application of surgical robot systems. The Venturebeat website reported that the UK medical startup CMR has successfully developed a new generation of robotic minimally invasive surgery technology and has received funding from ABB Technology Ventures, LGT Global Invest and Cambridge Innovation Capital. Among them, ABB is not only one of the world's largest engineering companies, but also an industry leader in the development of a new generation of universal robot minimally invasive surgery systems. The main reason for ABB's investment in CMR is that the new generation of minimally invasive surgery platform developed by CMR is a medical field with great potential for development in the future. CMR said that prior to this financing, CMR had raised about $5.2 million in funding for clinically general experimental research and was actively involved in production and commercialization with the goal of obtaining regulatory approval. Since the assistance of the robot can improve the accuracy and safety of the key links in the surgery, it can eliminate the trouble of the doctor's hand. In recent years, many research groups around the world are engaged in the research of telemedicine robots, and the remote control minimally invasive surgery is in the millennium. It has been widely used. The world's first telesurgery was in 2001, when New York surgeons removed the gallbladder from patients in France and established a global development in basic surgery. In recent years, a large number of robotic surgeries have been used in "keyholesurgery" and "laparoscopic surgery". These types of surgery are also called "minimally invasive surgery". Due to the advanced tools of the surgical robot, the surgery can be performed more. Smooth, there are many advantages, including a smaller wound area, less bleeding, less pain during surgery, shorter healing periods, and reduced risk of infection. Well-known robots such as the “Da Vinci Surgical Robot†are advanced robotic platforms capable of performing complex surgical procedures and are currently approved by the United States for general surgery and cardiology in adults and children. Surgical robots can improve the quality of physicians' work, and the future is extremely valuable. Experts estimate that the global surgical robotic system market will have a business opportunity of about $3.3 billion in 2014 and reach $10 billion by 2020. Health care startup Auris Surgical Robotics has raised $150 million, Medrobotics raised $25 million, and French company Medtech has received $15 million. At present, the work of surgical robots is mainly auxiliary, and must be worked with well-trained surgeons. The technology of unmanned surgery is still in its infancy, and it is not a major development area at this stage. Robots have their own precision tools and equipment, such as high-resolution 3D cameras, consoles, etc., depending on the application. Industry experts believe that although there are major breakthroughs in the experiment, the cost of surgical robots is expensive, and remote surgery requires immediate interactive message feedback. The speed and stability of the current message transmission needs to be strengthened, but it is still expected to be used in a larger scope in the future. For the benefit of mankind. Hebei Hupai Aodi Cabinet Industry Co.,Ltd. , https://www.hupaiaodi.com